/PRNewswire/ -- Chiesi Global Rare Diseases, a business unit of the Chiesi Group established to deliver innovative therapies and solutions for people affected...

Related Keywords

United States , Versailles , Îe De France , France , Canada , Sweden , Italy , United Kingdom , China , Israel , Jerusalem , Israel General , Boston , Massachusetts , Giacomo Chiesi , Ozlem Goker Alpan , Consiglio Nazionale Delle Ricerche , Angela Messina , Armand Trousseau , John Bernat , David Warnock , Adam Daley , Alessio Pappagallo , Dominique Germain , Benedicte Heron , Derralynn Hughes , Chiara Travagin , Treatment Center , Access Program , Reference Centre For Lysosomal Diseases , Roche Guyon University Hospital , Emory University School Of Medicine , University Of Alabama At Birmingham , Berry Company Public Relations , Department Of Pediatric Neurology , University Of Versailles , B Corp , Chiesi Group Media Contacts , Chiesi Group , University Of Iowa Hospitals , Rare Disorders Research , Division Of Medical Genetics , University College London , Chiesi Global Rare Diseases , Inborn Errors , Annual Symposium , Chiesi Global Rare , Iowa Hospitals , Expanded Access , Fabry Disease Monitoring , Medical Genetics , Royal Free , Dawn Laney , Emory University School , Pediatric Neurology , Preference Centre , Lysosomal Diseases , Consiglio Nazionale , Important Safety Information , Full Prescribing Information , Hypersensitivity Reactions , Infusion Associated Reactions , Associated Reactions , Reproductive Potential , Global Rare Diseases , Benefit Corporation , Global Rare , Infection Control , Health Care Amp Hospitals , Medical Pharmaceuticals , Pharmaceuticals , Clinical Trials Amp Medical Discoveries , Trade Show News ,